Navigation Links
2 BUSM faculty receive Alzheimer's disease grants

(Boston) - David Harris, MD, PhD, chair and professor of biochemistry and Benjamin Wolozin, MD, PhD, professor of pharmacology and experimental therapeutics and neurology at Boston University School of Medicine (BUSM), have received Massachusetts Neuroscience Consortium (MNC) Awards. Each will receive a $250,000 grant allowing their teams to explore new therapeutic targets for Alzheimer's disease.

Harris is developing a novel approach to the therapy of Alzheimer's disease based on targeting a newly recognized molecular pathway responsible for neurodegeneration. Based on this approach, drug compounds have the potential to overcome some of the limitations of existing medications. Current treatments are largely ineffective and do not halt the cognitive decline associated with the disease.

"This award will significantly enhance our ability to develop improved therapies for Alzheimer's disease by allowing us to interact with industry partners, which is an important element of drug development," said Harris.

Harris' laboratory at BUSM investigates the molecular and cellular mechanisms underlying two classes of human neurodegenerative disorders: prion diseases and Alzheimer's disease. Prion and Alzheimer's diseases are part of a larger group of neurodegenerative disorders, including Parkinson's, Huntington's and several other diseases.

Wolozin is developing compounds that inhibit aggregation and toxicity caused by TDP-43, a protein that forms aggregates in Alzheimer's disease as well as other diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia. He is known for his Alzheimer's research, which focuses on the role of cholesterol in Alzheimer's disease and investigating mechanisms in which statins may impact the pathophysiology of the disease.

"This grant emphasizes the importance of collaboration between BUSM and development programs at major pharmaceutical companies in the Boston area," said Wolozin.

Principal Investigator of the project, Wolozin is working with Marcie Glicksman, PhD, and Kevin Hodgetts, PhD, co-directors of the Laboratory for Drug Discovery in Neurodegeneration (LDDN) at Brigham and Women's Hospital. The teams will divide the work between biology and chemistry.


Contact: Gina Orlando
Boston University Medical Center

Related medicine news :

1. Faculty of 1000 announces partnership between F1000Prime and docwise
2. Creighton University Welcomes New Faculty Member to Master of Public Health Program
3. Faculty List for Continuing Medical Education (CME) Conference 17th Annual Conference on Hypertension, Diabetes and Dyslipidemia Released by Continuing Education Company
4. 8th edition of LSUHSC facultys textbook published
5. Concordia University, Nebraska Faculty Member Headed to Guatemala for Mission Trip
6. Renowned medical genetics pioneer to join LA BioMed faculty
7. MCG faculty member, former hostage returns to Kuwait as Fulbright Scholar
8. Radiation Research Society honors 2 faculty
9. RIT receives $3.2 million award from the NSF to advance female faculty
10. Faculty from UCLA Center for Autism Research and Treatment receive multiple NIH awards
11. College biology faculty named Leadership Fellows
Post Your Comments:
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
Breaking Medicine Technology: